# Ensysce Biosciences, Inc.: Form 8-K, filed Nov 21, 2024

- Company: [Ensysce Biosciences, Inc.](/companies/ensc.md) (CIK 1716947)
- Form: 8-K
- Filed: 2024-11-21
- Accepted by EDGAR: Nov 21, 2024, 16:15 ET
- Period: 2024-11-21
- Accession: 0001493152-24-047149
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/form8-k.htm

Filed Nov 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-047149. Last ingested by Listed: Oct 30, 2026, 17:37 ET. No prices; not investment advice.